Genomic and proteomic biomarkers for cancer: A multitude of opportunities
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1796 (2) , 176-193
Abstract
No abstract availableKeywords
This publication has 270 references indexed in Scilit:
- Absence of MGMT promoter methylation in endometrial cancerGynecologic Oncology, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancerCancer Letters, 2008
- Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancerThe Journal of Pathology, 2007
- Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98Breast Cancer Research and Treatment, 2007
- Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancerCancer, 2007
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion columnProteomics, 2006
- Computational Proteomics Analysis System (CPAS): An Extensible, Open-Source Analytic System for Evaluating and Publishing Proteomic Data and High Throughput Biological ExperimentsJournal of Proteome Research, 2005
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002